| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 02, 2017 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| May 25, 2017 | SVP/GM, Vascular Access | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 13,052 | |
| May 25, 2017 | SVP/GM, Vascular Access | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| May 25, 2017 | SVP/GM, Vascular Access | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| May 25, 2017 | SVP/GM, Global Vascular | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 10,000 | |
| May 25, 2017 | SVP/GM, Global Vascular | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| May 25, 2017 | SVP/GM, Global Vascular | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| May 23, 2017 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 788 | $15.82 | 12,264 | |
| Apr 24, 2017 | SVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,585 | $15.78 | 32,076 | |
| Apr 14, 2017 | Director, Ten Percent Owner | Form 4 | Other acquisition or disposition | -- | -- | 23,988 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.